Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoulika Kherrouche

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Biochemical Journal|July 20, 2004
The NRF-1/alpha-PAL transcription factor regulates human E2F6 promoter activityZoulika Kherrouche, Yvan De Launoit, Didier Monte
Biochemical and Biophysical Research Communications|April 15, 2004
Human E2F6 is alternatively spliced to generate multiple protein isoformsZoulika Kherrouche, Yvan De Launoit, Didier Monté
The Journal of General Virology|November 24, 1999
Atypical nucleoprotein complexes mediate CRE-dependent regulation of the early promoter of minute virus of miceManoussos Perros, François Fuks, Zoulika Kherrouche, et al.
Medecine Sciences : M/S|October 15, 2014
[Thirty years of Met receptor research: from the discovery of an oncogene to the development of targeted therapies]Rémi Montagne, Alessandro Furlan, Zoulika Kherrouche, et al.
The Biochemical Journal|March 4, 2006
ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F target geneZoulika Kherrouche, Alexandre Blais, Elisabeth Ferreira, et al.
Cancer Research|November 21, 2014
Thirty years of research on met receptor to move a biomarker from bench to bedsideAlessandro Furlan, Zoulika Kherrouche, Rémi Montagne, et al.
Oncogene|May 25, 2021
When the MET receptor kicks in to resist targeted therapiesMarie Fernandes, Philippe Jamme, Alexis B Cortot, et al.
Melanoma Research|April 12, 2003
Expression of the c-kit receptor in choroidal melanomasFrédéric Mouriaux, Zoulika Kherrouche, Claude-Alain Maurage, et al.
Chemical Communications (Cambridge, England)|March 15, 2011
Preparation and characterization of Zonyl-coated nanodiamonds with antifouling propertiesLionel Marcon, Zoulika Kherrouche, Joël Lyskawa, et al.
Journal of the National Cancer Institute|April 5, 2017
Exon 14 Deleted MET Receptor as a New Biomarker and Target in CancersAlexis B Cortot, Zoulika Kherrouche, Clotilde Descarpentries, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Biochemical Journal|July 20, 2004
The NRF-1/alpha-PAL transcription factor regulates human E2F6 promoter activityZoulika Kherrouche, Yvan De Launoit, Didier Monte
Biochemical and Biophysical Research Communications|April 15, 2004
Human E2F6 is alternatively spliced to generate multiple protein isoformsZoulika Kherrouche, Yvan De Launoit, Didier Monté
The Journal of General Virology|November 24, 1999
Atypical nucleoprotein complexes mediate CRE-dependent regulation of the early promoter of minute virus of miceManoussos Perros, François Fuks, Zoulika Kherrouche, et al.
Medecine Sciences : M/S|October 15, 2014
[Thirty years of Met receptor research: from the discovery of an oncogene to the development of targeted therapies]Rémi Montagne, Alessandro Furlan, Zoulika Kherrouche, et al.
The Biochemical Journal|March 4, 2006
ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F target geneZoulika Kherrouche, Alexandre Blais, Elisabeth Ferreira, et al.
Cancer Research|November 21, 2014
Thirty years of research on met receptor to move a biomarker from bench to bedsideAlessandro Furlan, Zoulika Kherrouche, Rémi Montagne, et al.
Oncogene|May 25, 2021
When the MET receptor kicks in to resist targeted therapiesMarie Fernandes, Philippe Jamme, Alexis B Cortot, et al.
Melanoma Research|April 12, 2003
Expression of the c-kit receptor in choroidal melanomasFrédéric Mouriaux, Zoulika Kherrouche, Claude-Alain Maurage, et al.
Chemical Communications (Cambridge, England)|March 15, 2011
Preparation and characterization of Zonyl-coated nanodiamonds with antifouling propertiesLionel Marcon, Zoulika Kherrouche, Joël Lyskawa, et al.
Journal of the National Cancer Institute|April 5, 2017
Exon 14 Deleted MET Receptor as a New Biomarker and Target in CancersAlexis B Cortot, Zoulika Kherrouche, Clotilde Descarpentries, et al.
Pageof 3